blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1392296

EP1392296 - THIAZOLIDINEDIONES ALONE OR IN CONBINATION WITH OTHER THERAPEUTIC AGENTS FOR INHIBITING OR REDUCING TUMOUR GROWTH [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.01.2009
Database last updated on 13.07.2024
Most recent event   Tooltip09.01.2009Application deemed to be withdrawnpublished on 11.02.2009  [2009/07]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4002 Basel / CH
[N/P]
Former [2004/10]For all designated states
F. HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124
4002 Basel / CH
Inventor(s)01 / BAUER, Sabine
Mechthildenstrasse 39
80639 München / DE
02 / MEYER, Markus
Maurenweg 6
79395 Neuenburg / DE
03 / SCHNITZER, Tobias
Bellizonastrasse 5
81475 Muenchen / DE
04 / SCHUELL, Christine
Waldstrasse 1
82377 Penzberg / DE
05 / WOLFF, Hans-Peter
Huegelstrasse 11
69469 Weinheim / DE
 [2004/12]
Former [2004/10]01 / BAUER, Sabine
Primelstrasse 3a
82377 Penzberg / DE
02 / MEYER, Markus
Maurenweg 6
79395 Neuenburg / DE
03 / SCHNITZER, Tobias
Bellizonastrasse 5
81475 Muenchen / DE
04 / SCHUELL, Christine
Wiesenpromenade West 42
64673 Zwingenberg / DE
05 / WOLFF, Hans-Peter
Huegelstrasse 11
69469 Weinheim / DE
Representative(s)Schreiner, Siegfried
Roche Diagnostics GmbH Patent Department (TR-E) Nonnenwald 2
82377 Penzberg / DE
[2008/43]
Former [2004/10]Schreiner, Siegfried, Dr.
Roche Diagnostics GmbH, Patent Department Pharma (TR-E), P.O. Box 1152
82372 Penzberg / DE
Application number, filing date02730101.904.04.2002
[2004/10]
WO2002EP03746
Priority number, dateEP2001010782006.04.2001         Original published format: EP 01107820
[2004/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02080913
Date:17.10.2002
Language:EN
[2002/42]
Type: A1 Application with search report 
No.:EP1392296
Date:03.03.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2002 takes the place of the publication of the European patent application.
[2004/10]
Search report(s)International search report - published on:EP17.10.2002
ClassificationIPC:A61K31/425, A61P35/00, C07D417/12, C07D417/14
[2004/10]
CPC:
A61K31/425 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
C07D417/12 (EP,US); C07D417/14 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/10]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:THIAZOLIDINDIONE ALLEIN ODER IN KOMBINATION MIT ANDEREN THERAPEUTISCHEN WIRKSTOFFEN ZUR HEMMUNG DES TUMORWACHSTUMS[2008/14]
English:THIAZOLIDINEDIONES ALONE OR IN CONBINATION WITH OTHER THERAPEUTIC AGENTS FOR INHIBITING OR REDUCING TUMOUR GROWTH[2004/10]
French:THIAZOLIDINEDIONES SEULS OU COMBINES AVEC D'AUTRES AGENTS THERAPEUTIQUES AFIN D'INHIBER OU DE REDUIRE LA CROISSANCE TUMORALE[2004/10]
Former [2004/10]THIAZOLIDINDIONE ALLEIN ODER IN KOMBINATION MIT ANDEREN THEURAPEUTISCHEN WIRKSTOFFEN ZUR HEMMUNG DES TUMORWACHSTUMS
Entry into regional phase06.11.2003National basic fee paid 
06.11.2003Designation fee(s) paid 
06.11.2003Examination fee paid 
Examination procedure21.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.11.2003Examination requested  [2004/10]
28.11.2005Despatch of a communication from the examining division (Time limit: M06)
08.09.2006Reply to a communication from the examining division
10.04.2008Communication of intention to grant the patent
22.08.2008Application deemed to be withdrawn, date of legal effect  [2009/07]
24.09.2008Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/07]
Request for further processing for:08.09.2006Request for further processing filed
08.09.2006Full payment received (date of receipt of payment)
Request granted
22.09.2006Decision despatched
Fees paidRenewal fee
06.04.2004Renewal fee patent year 03
04.04.2005Renewal fee patent year 04
27.03.2006Renewal fee patent year 05
10.04.2007Renewal fee patent year 06
18.03.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO9427995  (BOEHRINGER MANNHEIM GMBH [DE], et al) [AD] 1-8 * the whole document *;
 [DY]WO9825598  (DANA FARBER CANCER INST INC [US], et al) [DY] 1-8 * abstract * * page 4, lines 18-27 * * page 21, line 12 - page 22, line 7 * * page 22, lines 13,14 * * page 23, lines 3-13 * * claim - *;
 [AD]WO9842704  (BOEHRINGER MANNHEIM GMBH [DE], et al) [AD] 1-8 * the whole document *;
 [Y]WO9948529  (WARNER LAMBERT CO [US], et al) [Y] 1-8 * abstract * * page 3, lines 7,8 * * claim - *;
 [DY]WO0030628  (GENENTECH INC [US]) [DY] 1-8 * abstract * * page 6, line 38 * * page 22, line 24 - page 23, line 6 * * claim - *;
 [A]WO0179202  (HOFFMANN LA ROCHE [CH]) [A] 1-8* the whole document *;
 [DY]  - FUERNSINN C ET AL, "CHRONIC AND ACUTE EFFECTS OF THIAZOLIDINEDIONES BM13.1258 AND BM15.2054 ON RAT SKELETAL MUSCLE GLUCOSE METABOLISM", BRITISH JOURNAL OF PHARMACOLOGY, BASINGSTOKE, HANTS, GB, (1999), vol. 128, no. 6, ISSN 0007-1188, pages 1141 - 1148, XP001017891 [DY] 1-8 * abstract *

DOI:   http://dx.doi.org/10.1038/sj.bjp.0702886
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.